Outbound investment screening

Outbound investment screening is the review, notification, and prohibition of domestic capital flowing into an adversary's strategic sectors. It reverses the direction of classical investment security: where inbound screening keeps adversary money out of the home economy, outbound screening keeps home money, and the know-how, networks, and legitimacy that travel with it, out of the adversary's, which is why the US programme is routinely called "reverse CFIUS".

Mechanism

The instrument closes a gap that export controls cannot reach. A controlled technology can be denied at the border, but capital plus intangibles, the venture investor's mentoring, talent access, market validation, and follow-on funding, builds adversary capability without any controlled item crossing a frontier. Screening therefore attaches obligations to the investor rather than the good: covered persons must notify or must not undertake defined transaction classes (acquisitions, venture and growth investment, joint ventures, certain fund commitments) involving entities in designated sectors of designated countries. The design problem is precision at scale; capital is fungible and global, so the perimeter must be drawn tightly enough to police and broadly enough to matter.

Legal and institutional basis

The United States established a dedicated regime through Executive Order 14105 of August 2023 and 31 CFR part 850, effective 2 January 2025. It prohibits or requires notification of defined covered transactions by US persons involving covered foreign persons connected to countries listed in the rule's country-of-concern annex. The three technology categories are semiconductors and microelectronics, quantum information technologies and artificial intelligence systems, each bounded by transaction and technical definitions. The European Commission's Recommendation (EU) 2025/63 instead asked Member States to review specified outbound investments and report by 30 June 2026. It was a monitoring recommendation, not the binding US transaction regime. The instrument sits alongside Technology denial and Delisting and capital-market exclusion.

The US rule also excludes specified publicly traded securities and other excepted transactions, so it is not a general prohibition on portfolio investment.

Effects and contestation

The regime's early perimeter targets defined capabilities rather than aggregate investment flows. Contestation runs on three lines. Efficacy: capital may be replaced from other sources, so any effect depends on whether investor expertise and networks are genuinely scarce. Scope: expanding technical or transaction definitions could convert a targeted tool into broader financial separation. Reciprocity: normalising state review of private capital allocation creates a precedent other jurisdictions can use. Proponents answer that the associated know-how, not only the money, is the object of denial. Assessment remains premature. The binding US regime took effect only in January 2025, while the EU measure reviewed here was a recommendation with a June 2026 reporting deadline. Claims about expansion, capability denial or substitution require a later rule, measured transaction data and a stated observation period rather than inference from the existence of screening authority.

See also

Committee on Foreign Investment in the United States (CFIUS) · Executive Order 14105 (2023) · Technology denial · Delisting and capital-market exclusion · Economic statecraft

Sources

• US Treasury, Outbound Investment Security Program, accessed 30 July 2026.
• 31 CFR part 850, accessed 30 July 2026.
• Executive Order 14105, accessed 30 July 2026.
• Commission Recommendation (EU) 2025/63, accessed 30 July 2026.